- Report
- August 2025
- 80 Pages
Japan
From €2255EUR$2,595USD£1,963GBP
- Report
- August 2025
- 80 Pages
Poland
From €2255EUR$2,595USD£1,963GBP
- Report
- August 2025
- 80 Pages
Russia
From €2255EUR$2,595USD£1,963GBP
- Report
- August 2025
- 80 Pages
Vietnam
From €2255EUR$2,595USD£1,963GBP
- Report
- August 2025
- 100 Pages
Brazil, China, India, ... Brazil, China, India, Russia, South Africa
From €3298EUR$3,795USD£2,870GBP
- Report
- August 2025
- 100 Pages
Middle East
From €3298EUR$3,795USD£2,870GBP
Ulipristal Acetate (UPA) is a medication used in the field of Sexual and Reproductive Health (SRH). It is a selective progesterone receptor modulator (SPRM) used for emergency contraception and for the treatment of uterine fibroids. UPA is a safe and effective option for women seeking emergency contraception, as it is more effective than other methods and can be taken up to five days after unprotected intercourse. It is also used to treat symptomatic uterine fibroids, as it can reduce the size of the fibroids and reduce associated symptoms.
UPA is available in many countries, including the United States, Canada, and the European Union. It is available in both generic and branded forms, and is typically sold as a single-dose tablet.
Some companies in the UPA market include HRA Pharma, Teva Pharmaceuticals, and Mylan. Show Less Read more